Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 11, 2012, Pages 1826-1836

  Arsikin, Katarina ^a   Kravic Stevovic, Tamara ^a   Jovanovic, Maja ^a   Ristic, Biljana ^a   Tovilovic, Gordana ^b   Zogovic, Nevena ^b   Bumbasirevic, Vladimir ^a   Trajkovic, Vladimir ^a   Harhaji Trajkovic, Ljubica ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

6 Hydroxydopamine; AMPK; Autophagy; Neurotoxicity; Oxidative stress; P38

Indexed keywords

ACETYLCYSTEINE; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDOPAMINE; PROTEIN P62; RAPAMYCIN; S6 KINASE;

ACIDIFICATION; APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY;

ACETYLCYSTEINE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; AUTOPHAGY; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; OXIDOPAMINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

MAMMALIA; RAPTORES;

EID: 84865550601     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.08.006     Document Type: Article

References (50)

1. Klockgether T. Parkinson's disease: clinical aspects. Cell Tissue Res. 2004, 318:115-120.
2. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
3. Senoh S., Creveling C.R., Udenfriend S., Witkop B. Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine. J. Am. Chem. Soc. 1959, 81:6236-6240.
4. Curtius H.C., Wolfensberger M., Steinmann B., Redweik U., Siegfried J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J. Chromatogr. 1974, 99:529-540.
5. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 1974, 249:2447-2452.
6. Yorimitsu T., Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005, 12:1542-1552.
7. White E. Autophagic cell death unraveled: pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 2008, 4:399-401.
8. Ghavami S., Asoodeh A., Klonisch T., Halayko A.J., Kadkhoda K., Kroczak T.J., Gibson S.B., Booy E.P., Naderi-Manesh H., Los M. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J. Cell. Mol. Med. 2008, 12:1005-1022.
9. Ghavami S., Eshragi M., Ande S.R., Chazin W.J., Klonisch T., Halayko A.J., McNeill K.D., Hashemi M., Kerkhoff C., Los M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 2010, 20:314-331.
10. Maycotte P., Thorburn A. Autophagy and cancer therapy. Cancer Biol. Ther. 2011, 11:127-137.
11. Batlevi Y., La Spada A.R. Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging. Neurobiol. Dis. 2011, 43:46-51.
12. Lee J.A. Neuronal autophagy: a housekeeper or a fighter in neuronal cell survival?. Exp. Neurobiol. 2012, 21:1-8.
13. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
14. Meijer A.J., Codogno P. Regulation and role of autophagy in mammalian cells. Int. J. Biochem. Cell Biol. 2004, 36:2445-2462.
15. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
16. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. 2009, 196:65-80.
17. Xu Z.X., Liang J., Haridas V., Gaikwad A., Connolly F.P., Mills G.B., Gutterman J.U. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ. 2007, 14:1948-1957.
18. Papandreou A.L., Lim K., Laderoute N.C. Denko, Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ. 2008, 15:1572-1581.
19. Harhaji-Trajkovic L., Vilimanovich U., Kravic-Stevovic T., Bumbasirevic V., Trajkovic V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J. Cell. Mol. Med. 2009, 13:3644-3654.
20. Filomeni G., Desideri E., Cardaci S., Graziani I., Piccirillo S., Rotilio G., Ciriolo M.R. Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 2010, 6:202-216.
21. Vingtdeux V., Giliberto L., Zhao H., Chandakkar P., Wu Q., Simon J.E., Janle E.M., Lobo J., Ferruzzi M.G., Davies P., Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 2010, 285:9100-9113.
22. Nakatsu Y., Kotake Y., Takai N., Ohta S. Involvement of autophagy via mammalian target of rapamycin (mTOR) inhibition in tributyltin-induced neuronal cell death. J. Toxicol. Sci. 2010, 35:245-251.
23. Marin C., Aguilar E. In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. Neurochem. Int. 2011, 58:521-526.
24. Dagda R.K., Zhu J., Kulich S.M., Chu C.T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 2008, 4:770-782.
25. Li L., Wang X., Fei X., Xia L., Qin Z., Liang Z. Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci. Lett. 2011, 489:62-67.
26. Fei X.F., Qin Z.H., Xiang B., Li L.Y., Han F., Fukunaga K., Liang Z.Q. Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Res. 2009, 1264:85-97.
27. Cheng H.C., Kim S.R., Oo T.F., Kareva T., Yarygina O., Rzhetskaya M., Wang C., During M., Talloczy Z., Tanaka K., Komatsu M., Kobayashi K., Okano H., Kholodilov N., Burke R.E. Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. J. Neurosci. 2011, 31:2125-2135.
28. Kaludjerovic G.N., Miljkovic D., Momcilovic M., Djinovic V.M., Mostarica Stojkovic M., Sabo T.J., Trajkovic V. Novel platinum(IV) complexes induce rapid tumor cell death in vitro. Int. J. Cancer 2005, 116:479-486.
29. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
30. Ichimura Y., Kumanomidou T., Sou Y.S., Mizushima T., Ezaki J., Ueno T., Kominami E., Yamane T., Tanaka K., Komatsu M. Structural basis for sorting mechanism of p62 in selective autophagy. J. Biol. Chem. 2008, 283:22847-22857.
31. Shaw M.M., Gurr W.K., McCrimmon R.J., Schorderet D.F., Sherwin R.S. 5'AMP-activated protein kinase alpha deficiency enhances stress-induced apoptosis in BHK and PC12 cells. J. Cell. Mol. Med. 2007, 11:286-298.
32. Caramés B., Hasegawa A., Taniguchi N., Miyaki S., Blanco F.J., Lotz M. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann. Rheum. Dis. 2012, 71:575-581.
33. Gomez-Lazaro M., Galindo M.F., Concannon C.G., Segura M.F., Fernandez-Gomez F.J., Llecha N., Comella J.X., Prehn J.H., Jordan J. 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J. Neurochem. 2008, 104:1599-1612.
34. Luo Y., Zou P., Zou J., Wang J., Zhou D., Liu L. Autophagy regulates ROS-induced cellular senescence via p21 in a p38 MAPKα dependent manner. Exp. Gerontol. 2011, 46:860-867.
35. Zheng Y.H., Tian C., Meng Y., Qin Y.W., Du Y.H., Du J., Li H.H. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J. Cell. Physiol. 2012, 227:127-135.
36. Kumar S., Jiang M.S., Adams J.L., Lee J.C. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 1999, 263:825-831.
37. Choi W.S., Eom D.S., Han B.S., Kim W.K., Han B.H., Choi E.J., Oh T.H., Markelonis G.J., Cho J.W., Oh Y.J. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 2004, 279:20451-20460.
38. Giménez-Xavier P., Francisco R., Santidrián A.F., Gil J., Ambrosio S. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model. Neurotoxicology 2009, 30:658-665.
39. Gao P., Bauvy C., Souquère S., Tonelli G., Liu L., Zhu Y., Qiao Z., Bakula D., Proikas-Cezanne T., Pierron G., Codogno P., Chen Q., Mehrpour M. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J. Biol. Chem. 2010, 285:25570-25581.
40. Zhu J.H., Horbinski C., Guo F., Watkins S., Uchiyama Y., Chu C.T. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 2007, 170:75-86.
41. Fimia M., Piacentini M. Toward the understanding of autophagy regulation and its interplay with cell death pathways. Cell Death Differ. 2009, 16:933-934.
42. Salazar M., Carracedo A., Salanueva I.J., Hernández-Tiedra S., Lorente M., Egia A., Vázquez P., Blázquez C., Torres S., García S., Nowak J., Fimia G.M., Piacentini M., Cecconi F., Pandolfi P.P., González-Feria L., Iovanna J.L., Guzmán M., Boya P., Velasco G. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 2009, 119:1359-1372.
43. Bae C.H., Kim J.W., Ye S.B., Song S.Y., Kim Y.W., Park S.Y., Kim Y.D. AMPK induces MUC5B expression via p38 MAPK in NCI-H292 airway epithelial cells. Biochem. Biophys. Res. Commun. 2011, 409:669-674.
44. Kim J.H., Lee J.O., Lee S.K., Moon J.W., You G.Y., Kim S.J., Park S.H., Park J.M., Lim S.Y., Suh P.G., Uhm K.O., Song M.S., Kim H.S. The glutamate agonist homocysteine sulfinic acid stimulates glucose uptake through the calcium-dependent AMPK-p38 MAPK-protein kinase C zeta pathway in skeletal muscle cells. J. Biol. Chem. 2011, 286:7567-7576.
45. Kulich S.M., Horbinski C., Patel M., Chu C.T. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic. Biol. Med. 2007, 43:372-383.
46. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 1997, 12:25-31.
47. Chu C.T. Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease. Parkinsons Dis. 2011, 2011:789431.
48. Xilouri M., Stefanis L. Autophagy in the central nervous system: implications for neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 2010, 9:701-719.
49. Xilouri M., Stefanis L. Autophagic pathways in Parkinson disease and related disorders. Expert Rev. Mol. Med. 2011, 21(13):e8.
50. Yang Y., Fukui K., Koike T., Zheng X. Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. Eur. J. Neurosci. 2007, 26:2979-2988.